AF in a Patient with HT: Clinical Dilemmas and Evidence-based Management


Dr Paolo Verdecchia, Italy    19 December 2017

  1. In hypertensive patients with paroxysmal/persistent AF, RAAS inhibition with ACEIs/ARBs could prevent AF recurrence, but evidence is notyet conclusive.
  2. It is unclear whether achievement of more intensive BP control in anticoagulated patients with AF reduces the risk of thromboembolic stroke and serious bleeding.
  3. In the four pivotal trials of NOACs vs. warfarin in patients with nonvalvular AF, HT did not interfere with the effects of these drugs vs. warfarin.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.